Guidelines for good database selection and use in pharmacoepidemiology research

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 1, 2012, Pages 1-10

  Hall, Gillian C ^a   Sauer, Brian ^b   Bourke, Alison ^c   Brown, Jeffrey S ^d   Reynolds, Matthew W ^e   Casale, Robert Lo ^f  

^a Grimsdyke House   (United Kingdom)

^b UNIVERSITY OF UTAH   (United States)

^c CSD Medical Research   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNITED BIOSOURCE CORPORATION   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Epidemiology; Guidance; Health databases; Pharmaceuticals; Research design

Indexed keywords

DATA BASE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE SYSTEM; MEDICAL DOCUMENTATION; NOTE; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH;

EID: 84855355879     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2229     Document Type: Note

References (13)

1. Motheral B, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D, et al. A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases. Value Health 2003; 6(2): 90-7.
2. Gliklich RE, Dreyer NA eds. Registries for Evaluating Patient Outcomes: A User's Guide. April 2007: .
3. Berger ML, Mamdani M, Atkins D, Johnson ML. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. Value Health 2009; 12(8): 1044-52.
4. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 2008; 17(2): 200-8.
5. Elm Ev, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies 10.1136/bmj.39335.541782.AD. BMJ 2007; 335(7624): 806-08.
6. ISPOR. (2010). "International Digest of Databases." Retrieved June 2010, from.
7. Brown JS, Holmes JH, Shah K, Hall K, Lazarus R, Platt R. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care 2010; 48(6 Suppl): S45-51.
8. Rassen JA, Avorn J, Schneeweiss S. Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases. Pharmacoepidemiol Drug Saf 2010; Aug;19(8): 848-57.
9. Brown JS, Lane K, Moore K, Platt R. Defining and Evaluating Possible Database Models to Implement the FDA Sentinel Initiative. Report to the U.S. Food and Drug Administration, Contract No. HHSF223200831315P; May 2009. From
10. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69: 4-14.
11. Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009; 18(2): 120-31.
12. Hennessy S, Bilker WB, Weber A, Strom BL. Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf 2003; 12(2): 103-11.
13. ® Users Group International Conference. SAS Institute Inc.: Cary, NC and Montréal, Canada, Paper 258-29 2004.